Judi Irving has resigned from her post as president and chief executive officer of HemaCare Corp., a Van Nuys, Calif., blood products and services company.
Irving, 49, who left the company on June 28, resigned to pursue other opportunities, according to a news statement issued by HemaCare. Board Chairman Julian Steffenhagan, 63, will act as interim CEO while a search is conducted for Irvings replacement.
Steffenhagan, who has sat on HemaCares board since 1997 and has been chairman since 2002, retired earlier this year from his position as senior vice president of the laboratory equipment and diagnostics company Beckman Coulter. -- by Shawn Rhea